Daniel L. Shawler

3.2k total citations
44 papers, 2.5k citations indexed

About

Daniel L. Shawler is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Daniel L. Shawler has authored 44 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 20 papers in Oncology and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Daniel L. Shawler's work include Immunotherapy and Immune Responses (15 papers), Cancer Research and Treatments (14 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). Daniel L. Shawler is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), Cancer Research and Treatments (14 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). Daniel L. Shawler collaborates with scholars based in United States, Canada and Hungary. Daniel L. Shawler's co-authors include Robert O. Dillman, Habib Fakhrai, Ivor Royston, Richard M. Bartholomew, Leia M. Smith, Argyrios N. Theofilopoulos, Frank J. Dixon, Robert E. Sobol, Duane E. Johnson and John Nemunaitis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Daniel L. Shawler

44 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel L. Shawler United States	21	1.3k	1.2k	908	821	295	44	2.5k
Stuart Lutzker United States	20	1.1k 0.9×	1.6k 1.3×	1.7k 1.9×	656 0.8×	182 0.6×	30	3.4k
Patricia Horan Hand United States	29	943 0.8×	1.2k 1.0×	1.6k 1.7×	1.5k 1.8×	168 0.6×	52	3.3k
Peisheng Hu United States	29	986 0.8×	812 0.7×	722 0.8×	697 0.8×	132 0.4×	62	2.0k
L J Old United States	27	1.5k 1.2×	675 0.6×	1.5k 1.7×	1.3k 1.5×	106 0.4×	44	2.9k
Gundram Jung Germany	31	1.7k 1.3×	1.4k 1.2×	871 1.0×	729 0.9×	69 0.2×	114	2.9k
Mark R. Albertini United States	28	1.1k 0.9×	1.2k 1.0×	1.0k 1.1×	332 0.4×	116 0.4×	97	2.4k
Robert E. Sobol United States	20	535 0.4×	797 0.7×	645 0.7×	226 0.3×	225 0.8×	43	1.8k
Ben K. Seon United States	27	642 0.5×	683 0.6×	1.5k 1.7×	529 0.6×	195 0.7×	100	2.6k
S. V. Litvinov Netherlands	18	629 0.5×	980 0.8×	1.3k 1.5×	648 0.8×	115 0.4×	28	2.4k
Hubert S. Chou United States	12	762 0.6×	1.2k 1.0×	1.2k 1.3×	315 0.4×	118 0.4×	13	2.2k

Countries citing papers authored by Daniel L. Shawler

Since Specialization

Citations

This map shows the geographic impact of Daniel L. Shawler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel L. Shawler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel L. Shawler more than expected).

Fields of papers citing papers by Daniel L. Shawler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel L. Shawler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel L. Shawler. The network helps show where Daniel L. Shawler may publish in the future.

Co-authorship network of co-authors of Daniel L. Shawler

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel L. Shawler. A scholar is included among the top collaborators of Daniel L. Shawler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel L. Shawler. Daniel L. Shawler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Giaccone, Giuseppe, Lyudmila Bazhenova, John Nemunaitis, et al.. (2015). A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer. European Journal of Cancer. 51(16). 2321–2329. 199 indexed citations

Karimi‐Busheri, Feridoun, et al.. (2010). The stability of breast cancer progenitor cells during cryopreservation: Maintenance of proliferation, self-renewal, and senescence characteristics. Cryobiology. 60(3). 308–314. 14 indexed citations

Nemunaitis, John, Michael Nemunaitis, Neil Senzer, et al.. (2009). Phase II trial of Belagenpumatucel-L, a TGF-β2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients. Cancer Gene Therapy. 16(8). 620–624. 116 indexed citations

Fakhrai, Habib, et al.. (2006). Phase I clinical trial of a TGF-β antisense-modified tumor cell vaccine in patients with advanced glioma. Cancer Gene Therapy. 13(12). 1052–1060. 71 indexed citations

Shawler, Daniel L., Richard M. Bartholomew, Richard Trauger, et al.. (2002). Antigenic and immunologic characterization of an allogeneic colon carcinoma vaccine. Clinical & Experimental Immunology. 129(1). 99–106. 18 indexed citations

Dorigo, Oliver, Daniel L. Shawler, Ivor Royston, et al.. (1998). Combination of Transforming Growth Factor β Antisense and Interleukin-2 Gene Therapy in the Murine Ovarian Teratoma Model. Gynecologic Oncology. 71(2). 204–210. 20 indexed citations

Shawler, Daniel L., Habib Fakhrai, Charles Van Beveren, et al.. (1997). Gene Therapy Approaches to Enhance Antitumor Immunity. Advances in pharmacology. 40. 309–337. 8 indexed citations

Fakhrai, Habib, Daniel L. Shawler, Charles Van Beveren, et al.. (1997). Construction and Characterization of Retroviral Vectors for Interleukin-2 Gene Therapy. Journal of Immunotherapy. 20(6). 437–448. 7 indexed citations

Fakhrai, Habib, Daniel L. Shawler, Ruth A. Gjerset, et al.. (1995). Cytokine Gene Therapy with Interleukin-2-Transduced Fibroblasts: Effects of IL-2 Dose on Anti-Tumor Immunity. Human Gene Therapy. 6(5). 591–601. 63 indexed citations

10.

Shawler, Daniel L., Oliver Dorigo, Ruth A. Gjerset, et al.. (1995). Comparison of Gene Therapy with Interleukin-2 Gene Modified Fibroblasts and Tumor Cells in the Murine CT-26 Model of Colorectal Carcinoma. Journal of Immunotherapy. 17(4). 201–208. 20 indexed citations

11.

Gjerset, Ruth A., Habib Fakhrai, Daniel L. Shawler, et al.. (1995). Characterization of a new human glioblastoma cell line that expresses mutant P53 and lacks activation of the PDGF pathway. In Vitro Cellular & Developmental Biology - Animal. 31(3). 207–214. 9 indexed citations

12.

Dillman, Robert O., et al.. (1994). Human Anti-Mouse Antibody Response in Cancer Patients Following Single Low-Dose Injections of Radiolabeled Murine Monoclonal Antibodies. PubMed. 9(1). 17–28. 28 indexed citations

13.

Shawler, Daniel L., et al.. (1988). Mechanisms of human CD5 modulation and capping induced by murine monoclonal antibody T101. Clinical Immunology and Immunopathology. 47(2). 219–229. 15 indexed citations

14.

Dillman, Robert O., Duane E. Johnson, Daniel L. Shawler, & Jim Koziol. (1988). Superiority of an acid-labile daunorubicin-monoclonal antibody immunoconjugate compared to free drug.. PubMed. 48(21). 6097–102. 58 indexed citations

15.

Shawler, Daniel L., et al.. (1987). Serologic and cellular assays to monitor therapy with murine monoclonal antibodies. Journal of Clinical Laboratory Analysis. 1(2). 184–190. 8 indexed citations

16.

Dillman, Robert O., Daniel L. Shawler, Duane E. Johnson, et al.. (1986). Preclinical trials with combinations and conjugates of T101 monoclonal antibody and doxorubicin.. PubMed. 46(10). 4886–91. 52 indexed citations

17.

Shawler, Daniel L., Susan B. Wormsley, R O Dillman, et al.. (1985). The use of monoclonal antibodies and flow cytometry to detect peripheral blood and bone marrow involvement of a diffuse, poorly differentiated lymphoma. International Journal of Immunopharmacology. 7(4). 423–432. 4 indexed citations

18.

Theofilopoulos, Argyrios N., Daniel L. Shawler, Robert Balderas, et al.. (1981). Specificities of NZB anti-H-2d CML reactions: role of Qa-1 and retroviral gp70 antigens.. The Journal of Immunology. 126(3). 1154–1159. 12 indexed citations

19.

Theofilopoulos, Argyrios N., Daniel L. Shawler, Robert A. Eisenberg, & Frank J. Dixon. (1980). Splenic immunoglobulin-secreting cells and their regulation in autoimmune mice.. The Journal of Experimental Medicine. 151(2). 446–466. 132 indexed citations

20.

Theofilopoulos, Argyrios N., Daniel L. Shawler, David H. Katz, & Frank J. Dixon. (1979). Patterns of immune reactivity in autoimmune murine strains. I. Cell-mediated immune responses induced by H-2 indentical and H-2 incompatible stimulator cells.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 122(6). 2319–27. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact